Belgium's MDxHealth signs U.S. deal for cancer test

BRUSSELS, Sept 3 Tue Sep 3, 2013 2:18am EDT

Related Topics

BRUSSELS, Sept 3 (Reuters) - Belgian biotech firm MDxHealth has signed a deal with U.S. healthcare network Stratose, which will give its prostate cancer testing product access to one of the largest networks in the United States.

MDxHealth said on Tuesday that with the signature of the Stratose agreement 80 million people in the United States will now have access to its prostate cancer test.

(Reporting by Robert-Jan Bartunek)

FILED UNDER:
A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article